Merck Millipore (Germany), Sartorius Stedim Biotech (France), Danaher Corporation (US), and Thermo Fisher Scientific (US) are the leading players in the aseptic sampling market
The aseptic sampling market is projected to reach USD 474 million by 2025 from USD 264 million in 2020, at a CAGR of 12.4% between 2020 and 2025. The increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities are the major factors driving the growth of the aseptic sampling market. Increased risk of pandemics and communicable diseases; and patent expiry of major drugs are likely to create significant growth opportunities for players in the market. However, the slow adoption of advanced technologies in biopharmaceutical manufacturing; and a slowdown in R&D activities due to the COVID-19 pandemic will challenge market growth.
Merck Millipore (Germany), Sartorius Stedim Biotech (France), Danaher Corporation (US), and Thermo Fisher Scientific (US)are the key players operating in this market. Other prominent players are Saint-Gobain (France), GEA Group (Germany), Avantor, Inc. (US), QualiTru Sampling Systems (US), Keofitt (Denmark), GEMÜ Group (US), W. L. Gore & Associates (US), Flownamics Analytical Instruments, Inc. (US), Lonza (Switzerland), and Trace Analytics (US).
To know about the assumptions considered for the study download the pdf brochure
Merck KGaA is one of the leading players in the aseptic sampling market. The company offers a strong portfolio of aseptic sampling products for biopharmaceutical manufacturing and process development. The company’s focus on inorganic growth strategies is evident from its recent partnership with Schneider Electric (France) to automate biopharmaceutical processes in the biopharmaceutical industry in China. Furthermore, Merck has a well-organized supply chain that delivers standard products in 24 to 48 hours worldwide. The company also focuses on the high-growth Asia region to increase its market share and revenue. In the last three years, the company opened life science centers in China, India, South Korea, and Singapore, to facilitate the supply of its products in the region. Such developments help in expanding Merck’s presence in the aseptic sampling market, thus maintaining its leading position.
Sartorius is a pioneer in single-use products that are currently used throughout all biopharmaceutical manufacturing processes. Its leading position can be attributed to its robust product portfolio and strong geographic presence. Sartorius’s products are manufactured and sold worldwide. The company’s products are marketed in the US and internationally through direct sales and independent distribution channels. Geographically, the company focuses on the North American and Asian markets. With its unique product offerings and strong sales and distribution networks, the company will experience high growth in this market.
Related Reports:
Aseptic Sampling Market by Type (Manual [Type (Traditional, Single-use), Product (Bags, Bottles, Syringes, Accessories)], Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO, CRO) - Global Forecast to 2025
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
